Cargando…
COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
BACKGROUND: Rheumatic diseases patients receiving Rituximab had severe COVID-19 disease. Although they had impaired humoral immune responses following COVID-19 vaccine, they had preserved cellular immune responses. Waning of COVID-19 antibody responses was observed within six months post vaccination...
Autores principales: | Alshukairi, Abeer N., Al-Omari, Awad, Albeity, Abdurahman, Alandijany, Thamir A., Hassan, Ahmed M., El-Kafrawy, Sherif A., Dada, Ashraf, Al Hroub, Mohammad K., El-Saed, Aiman, Bissar, Lina S., Daghmush, Radwan M., Al-Ghamdi, Saeed M.G., Perlman, Stanley, Azhar, Esam I., Halabi, Hussein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098803/ https://www.ncbi.nlm.nih.gov/pubmed/35623243 http://dx.doi.org/10.1016/j.jiph.2022.05.005 |
Ejemplares similares
-
Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation
por: Alshukairi, Abeer N., et al.
Publicado: (2022) -
Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture
por: Alshukairi, Abeer N., et al.
Publicado: (2021) -
Rapid and Reliable Detection of SARS-CoV-2 Using Direct RT-LAMP
por: El-Kafrawy, Sherif A., et al.
Publicado: (2022) -
Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2
por: Tolah, Ahmed M., et al.
Publicado: (2021) -
Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients
por: Almaghrabi, Reem S., et al.
Publicado: (2022)